Posted in | News | Business | Chemistry

Ashland Signs Agreement with Perstorp Polyols to Sell Pentaerythritol Business

Ashland Inc. (NYSE: ASH) today announced that its subsidiary, Hercules Incorporated, has signed a definitive agreement to sell its pentaerythritol (PE) business to Perstorp Polyols Inc., a subsidiary of Perstorp Holding AB. The purchase price was not disclosed.

The proposed asset purchase transaction includes transfer of the pentaerythritol business, related technology and a minor amount of equipment. It does not include the manufacturing plant in Louisiana, Mo., any real estate or employees. This transaction is consistent with Ashland's strategy to focus assets and energies in core specialty chemicals product areas.

PE is a versatile building block for the manufacture of alkyd resins, varnishes, PVC stabilizers, olefin antioxidants and other products.

The transaction is expected to close within 60 days, subject to fulfillment of certain conditions. The parties will work together to ensure a seamless transition with no disruption in customer service or supply.

Following transaction close, Ashland will continue to manufacture PE for Perstorp under a transitional supply arrangement until customer and other transitions are complete. Upon termination of the transition agreement, parts of the plant site and the associated coal-fired powerhouse will be shut down.

Ashland will continue to produce synthetic lubricants at the site. Through a supply agreement, Ashland will begin purchasing PE from Perstorp as a raw material for its continuing synthetic lubricants production.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.